Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
Authors
Keywords
Parasitic diseases, Lymph nodes, Leishmania, Promastigotes, T cells, Leishmaniasis, Amastigotes, Cytotoxic T cells
Journal
PLoS Neglected Tropical Diseases
Volume 12, Issue 8, Pages e0006701
Publisher
Public Library of Science (PLoS)
Online
2018-08-23
DOI
10.1371/journal.pntd.0006701
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
- (2017) Alireza Badirzadeh et al. PLoS Neglected Tropical Diseases
- Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
- (2017) Zahra Abdossamadi et al. PLoS Neglected Tropical Diseases
- Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model
- (2016) Maryam Heidari-Kharaji et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Enhanced paromomycin efficacy by solid lipid nanoparticle formulation againstLeishmaniain mice model
- (2016) M. Heidari-Kharaji et al. PARASITE IMMUNOLOGY
- Leishmaniasis in immunosuppressed individuals
- (2014) J. van Griensven et al. CLINICAL MICROBIOLOGY AND INFECTION
- Genetic Analysis of Leishmania donovani Tropism Using a Naturally Attenuated Cutaneous Strain
- (2014) Wen Wei Zhang et al. PLoS Pathogens
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Association of Pro-Inflammatory Cytokines and Iron Regulatory Protein 2 (IRP2) with Leishmania Burden in Canine Visceral Leishmaniasis
- (2013) Paulo Ricardo Porfírio do Nascimento et al. PLoS One
- Management of trypanosomiasis and leishmaniasis
- (2012) M. P. Barrett et al. BRITISH MEDICAL BULLETIN
- Monoterpenic aldehydes as potential anti-Leishmania agents: Activity of Cymbopogon citratus and citral on L. infantum, L. tropica and L. major
- (2012) M. Machado et al. EXPERIMENTAL PARASITOLOGY
- Isoenzyme and ultrastructural characterization of Leishmania tropica axenic amastigotes and promastigotes
- (2012) Gholam Reza Hatam et al. PARASITOLOGY RESEARCH
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Differential Regulation of Simultaneous Antitumor and Alloreactive CD8+ T-Cell Responses in the Same Host by Rapamycin
- (2011) S. Maleki Vareki et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sirolimus Enhances the Magnitude and Quality of Viral-Specific CD8+ T-Cell Responses to Vaccinia Virus Vaccination in Rhesus Macaques
- (2011) A. P. Turner et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Autophagy in protists
- (2011) Michael Duszenko et al. Autophagy
- Targeting mTOR with rapamycin: One dose does not fit all
- (2011) David A. Foster et al. CELL CYCLE
- Recent advances in leishmaniasis treatment
- (2011) Tatiana S. Tiuman et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection
- (2011) Satyanarayana Swamy Cheekatla et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Qualitative and quantitative polymerase chain reaction (PCR) for detection of Leishmania in spleen samples from naturally infected dogs
- (2011) Manuela da Silva Solcà et al. VETERINARY PARASITOLOGY
- The Susceptibility of Trypanosomatid Pathogens to PI3/mTOR Kinase Inhibitors Affords a New Opportunity for Drug Repurposing
- (2011) Rosario Diaz-Gonzalez et al. PLoS Neglected Tropical Diseases
- Cutting Edge: Rapamycin Augments Pathogen-Specific but Not Graft-Reactive CD8+ T Cell Responses
- (2010) I. R. Ferrer et al. JOURNAL OF IMMUNOLOGY
- Insulin-like growth factor-I induced and constitutive arginase activity differs among isolates of Leishmania derived from patients with diverse clinical forms of Leishmania braziliensis infection
- (2010) Célia M.V. Vendrame et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
- (2010) Steven D. Knight et al. ACS Medicinal Chemistry Letters
- Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
- (2009) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- mTOR regulates memory CD8 T-cell differentiation
- (2009) Koichi Araki et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started